Search Instructions:

* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Browse Items (34 total)

  • Tags: Virology

hide_me.png
Creator: University of Nebraska Medical Center / Nebraska Medicine
Subject: Training and Exercises
Item Type: Video
Date Last Updated: 2021-08-05
Description: Dr. Lawler held a news conference on August 5, 2021 to explain the Delta variant of COVID-19.

hide_me.png
Creator: NETEC
Subject: General
Item Type: Hyperlink
Date Last Updated: 2021-08-06
Description: A podcast by NETEC, the National Emerging Special Pathogens Education and Training Center, presented in cooperation with the CDC and funded by ASPR, the Assistant Secretary for Preparedness and Response. NETEC's podcast, covering a variety of topics.…

VOC Learning from Experiences in the UK and Germany Final Compressed.pdf
Creator: NETEC
Subject: Research
Item Type: Webinar
Date Last Updated: 2021-05-05
Description: Objectives: Define what constitutes a SARS-CoV-2 variant of concern  Describe clinical implications of variant of concern cases Identify what lessons US healthcare teams can learn from international experiences with variants of concern

Creator: the Oxford COVID-19 Vaccine Trial Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-30
Description: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant.

Creator: Thielen, P. M., S. Wohl, T. Mehoke, S. Ramakrishnan, M. Kirsche, O. Falade-Nwulia, N. S. Trovão, A. Ernlund, C. Howser, N. Sadowski, C. P. Morris, M. Hopkins, M. Schwartz, Y. Fan, V. Gniazdowski, J. Lessler, L. Sauer, M. C. Schatz, J. D. Evans, S.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-22
Description: The early COVID-19 pandemic was characterized by rapid global spread. In Maryland and Washington, DC, United States, more than 2500 cases were reported within 3 weeks of the first COVID-19 detection in March 2020.

Creator: Marks, Michael, Pere Millat-Martinez, Dan Ouchi, Chrissy h Roberts, Andrea Alemany, Marc Corbacho-Monné, Maria Ubals, Aurelio Tobias, Cristian Tebé, Ester Ballana, Quique Bassat, Bàrbara Baro, Martí Vall-Mayans, Camila G-Beiras, Nuria Prat, Jordi…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-02
Description: Scarce data are available on what variables affect the risk of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of symptomatic COVID-19, and, particularly, the relationship with viral load. We aimed to…

SARS-CoV-2 Mutations Variations and Strains Final Compressed.pdf
Creator: NETEC
Subject: Research
Item Type: Webinar
Date Last Updated: 2021-02-12
Description: In this webinar, we will define mutation and variant as they relate to SARS-CoV-2, discuss the importance of the current variants and mutations including future predictions surrounding the epidemiology of spread and modeling and describe what is…

Creator: Sridhar V Basavaraju, Monica E Patton, Kacie Grimm, Mohammed Ata Ur Rasheed, Sandra Lester, Lisa Mills, Megan Stumpf, Brandi Freeman, Azaibi Tamin, Jennifer Harcourt, Jarad Schiffer, Vera Semenova, Han Li, Bailey Alston, Muyiwa Ategbole, Shanna…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-11-30
Description: SARS-CoV-2, the virus that causes COVID-19 disease, was first identified in Wuhan, China in December 2019, with subsequent worldwide spread. The first U.S. cases were identified in January 2020.

Creator: McElroy, Anita K., Rama S. Akondy, David R. McLlwain, Han Chen, Zach Bjornson-Hooper, Nilanjan Mukherjee, Aneesh K. Mehta, Garry Nolan, Stuart T. Nichol, and Christina F. Spiropoulou.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-05-21
Description: A complete understanding of human immune responses to Ebola virus infection is limited by the availability of specimens and the requirement for biosafety level 4 (BSL-4) containment.